Compare SBLK & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SBLK | BHC |
|---|---|---|
| Founded | 2006 | N/A |
| Country | Greece | Canada |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.5B |
| IPO Year | 2007 | 1996 |
| Metric | SBLK | BHC |
|---|---|---|
| Price | $22.28 | $5.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $22.00 | $8.33 |
| AVG Volume (30 Days) | 1.9M | ★ 2.1M |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.58% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | $11.56 | $4.48 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $47.06 | ★ $12.19 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.06 | $4.28 |
| 52 Week High | $27.20 | $8.69 |
| Indicator | SBLK | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.58 | 35.56 |
| Support Level | $21.64 | $4.93 |
| Resistance Level | $27.20 | $7.22 |
| Average True Range (ATR) | 0.73 | 0.17 |
| MACD | -0.11 | 0.02 |
| Stochastic Oscillator | 30.42 | 14.42 |
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. The firm generates the majority of its revenue from Time charters and Voyage charters.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.